LPV

DRUG2 trials

Sponsors

Bristol-Myers Squibb, AZ Sint-Jan AV

Conditions

HIV InfectionsOxygen Saturation

Phase 3

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

CompletedNCT00272779

Bristol-Myers SquibbHIV Infections

Start: 2005-11-30End: 2008-10-31Updated: 2011-05-09

Unknown Phase

Impact of LPV During OFA on Postoperative Oxygen Saturation.

AZ Sint-Jan AVOxygen Saturation

Start: 2019-12-01End: 2021-12-31Target: 100Updated: 2019-12-10

Related Papers

Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.

2011-11-2517 citations

Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.

2010-12-0935 citations

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.

2008-08-01267 citations